Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCVX Vaxcyte, Inc.

休市中 08-23 16:00:00 EDT

79.35

+1.21

+1.55%

盘后79.35

+0.000.00%

19:18 EDT

最高80.14	最低77.98	成交量43.42万
今开78.89	昨收78.14	日振幅2.76%
总市值88.56亿	流通市值81.04亿	总股本1.12亿
成交额3,437万	换手率0.43%	流通股本1.02亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCVX","market":"US","secType":"STK","nameCN":"Vaxcyte, Inc.","latestPrice":79.35,"timestamp":1724443200000,"preClose":78.14,"halted":0,"volume":434154,"hourTrading":{"tag":"盘后","latestPrice":79.35,"preClose":79.35,"latestTime":"19:18 EDT","volume":20646,"amount":1638253.48,"timestamp":1724455132784},"delay":0,"floatShares":102125862,"shares":111609671,"eps":-4.59033,"marketStatus":"休市中","marketStatusCode":7,"change":1.21,"latestTime":"08-23 16:00:00 EDT","open":78.89,"high":80.14,"low":77.98,"amount":34368307.92024,"amplitude":0.027643,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.59033,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1591934400000,"adjPreClose":78.14,"postHourTrading":{"tag":"盘后","latestPrice":79.35,"preClose":79.35,"latestTime":"19:18 EDT","volume":20646,"amount":1638253.48,"timestamp":1724455132784},"volumeRatio":1.200911483335002,"impliedVol":1.0614,"impliedVolPercentile":0.9325},"requestUrl":"/m/hq/s/PCVX/tweets","defaultTab":"tweets","newsList":[{"id":"2458697314","title":"Vaxcyte, Inc.2024财年第二财季实现净利润-1.29亿美元，同比减少88.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458697314","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458697314?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:10","pubTimestamp":1723392642,"startTime":"0","endTime":"0","summary":"8月12日，Vaxcyte, Inc.公布财报，公告显示公司2024财年第二财季净利润为-1.29亿美元，同比减少88.76%；其中营业收入为0.00美元，每股基本收益为-1.10美元。从资产负债表来看，Vaxcyte, Inc.总负债1.01亿美元，其中短期债务7.29百万美元，资产负债比为20.67，流动比率为0.18。机构评级：截至2024年8月12日，当前有7家机构对Vaxcyte, Inc.目标价做出预测，其中目标均价为103.14美元，其中最低目标价为95.00美元，最高目标价为113.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105395904279&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081200105395904279&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"gpt_icon":0},{"id":"2458548296","title":"Vaxcyte, Inc.盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458548296","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458548296?lang=zh_cn&edition=full","pubTime":"2024-08-10 03:01","pubTimestamp":1723230068,"startTime":"0","endTime":"0","summary":"北京时间2024年08月10日03时01分，Vaxcyte, Inc.股票出现异动，股价快速拉升5.00%。截至发稿，该股报77.33美元/股，成交量31.0135万股，换手率0.28%，振幅4.98%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为2.44%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030109aefe2abe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240810030109aefe2abe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2457867856","title":"Vaxcyte 公司报告截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457867856","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457867856?lang=zh_cn&edition=full","pubTime":"2024-08-07 15:19","pubTimestamp":1723015170,"startTime":"0","endTime":"0","summary":"   * Vaxcyte Inc   报告，截至6月底的季度调整后每股亏损1.10美元，低于去年同期的每股收益-70美分。九位分析师对该季度的平均预期是每股亏损 98 美分。华尔街预期为每股亏损-1.10 美元至-86 美分。* Vaxcyte Inc报告的季度每股收益为亏损1.10美元。* 该公司当季亏损 1.287 亿美元。* Vaxcyte Inc本季度股价下跌了2.1%，今年迄今为止上涨了17.7%。华尔街对 Vaxcyte Inc 的 12 个月目标价中位数为 101.00 美元。本摘要由 LSEG 数据于世界协调时 8 月 7 日上午 07:19 自动生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Vaxcyte 公司报告截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2457704198","title":"BUZZ-莱林克认为礼来和 Sarepta 是动荡市场中的防御性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2457704198","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457704198?lang=zh_cn&edition=full","pubTime":"2024-08-06 20:36","pubTimestamp":1722947798,"startTime":"0","endTime":"0","summary":"    8月6日 - ** 经纪公司Leerink Partners称，礼来  和Sarepta Therapeutics  等股票有望在经济衰退的 \"动荡时期 \"跑赢大盘。** 默克  、Vaxcyte  和布鲁克  属于 \"现在值得重新审视 \"的股票，因为目前的抛售是买入这些股票的近期机会，这些股票最近因新闻流或股价表现困难而面临压力--Leerink** BMO Capital Markets称，SRPT、CRISPR Therapeutics   、Biomarin   和Legend Biotech   等公司因其强劲的产品收入而被 \"低估\"，这些公司可在大幅下跌时提供保护。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","LU1280957306.USD","BK4548","LU1814569148.SGD","IE00BJT1NW94.SGD","BK4535","LU2125909247.SGD","BK4121","SGXZ23171101.USD","LU0471298694.HKD","LU1037948897.HKD","LU1989771016.USD","BK4007","LU1066051498.USD","LEGN","IE00BJJMRZ35.SGD","IE00B19Z3B42.SGD","BMRN","LU1066051811.HKD","LU0251142724.SGD","IE00BKPKM429.USD","LU0256863811.USD","LU1988902786.USD","IE0002270589.USD","BUZZ","LU0251131958.USD","LU0965509283.SGD","LU0868494617.USD","BK4533","LLY","BRKR","LU0109391861.USD","LU1551013342.USD","TMO","LU1066051225.USD","LU2112291526.USD","IE00BJLML261.HKD","BK4559","LU0208291251.USD","MCK","IE00BLSP4239.USD","LU1023059063.AUD","LU1093756168.USD","IE00BBT3K403.USD","SRPT","COR","LU0211331839.USD","BK4534","PCVX"],"gpt_icon":1},{"id":"2456251599","title":"Vaxcyte, Inc.盘中异动 下午盘快速跳水5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456251599","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456251599?lang=zh_cn&edition=full","pubTime":"2024-08-03 02:46","pubTimestamp":1722624371,"startTime":"0","endTime":"0","summary":"北京时间2024年08月03日02时46分，Vaxcyte, Inc.股票出现波动，股价大幅下跌5.03%。截至发稿，该股报74.64美元/股，成交量56.1255万股，换手率0.52%，振幅3.49%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为2.23%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803024611aefcfe74&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240803024611aefcfe74&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE0009354923.USD","BK4139","PCVX"],"gpt_icon":0},{"id":"2456281329","title":"Vaxcyte Inc   预计每股亏损98美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281329","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281329?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:37","pubTimestamp":1722605820,"startTime":"0","endTime":"0","summary":"   * Vaxcyte Inc    将于8月6日公布截至2024年6月30日的财报() 预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Vaxcyte Inc每股亏损98美分。* 华尔街对 Vaxcyte Inc 的 12 个月目标价中位数为 101.00 美元，高于上一交易日 78.59 美元的收盘价。8月2日 - 本摘要于北京时间 8 月 2 日 13:36 机器生成。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Vaxcyte Inc   预计每股亏损98美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2452816080","title":"Vaxcyte, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452816080","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2452816080?lang=zh_cn&edition=full","pubTime":"2024-07-18 00:51","pubTimestamp":1721235104,"startTime":"0","endTime":"0","summary":"北京时间2024年07月18日00时51分，Vaxcyte, Inc.股票出现异动，股价大幅跳水5.05%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为2.24%。其相关个股中，Aptevo Therapeutics Inc.、Geovax Labs Inc C/Wts 29/09/2025、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Aptevo Therapeutics Inc.、Aditxt, Inc.、Longeveron Inc.较为活跃，换手率分别为3356.22%、1383.83%、294.87%，振幅较大的相关个股有Aptevo Therapeutics Inc.、Aditxt, Inc.、4D Molecular Therapeutics, Inc.，振幅分别为76.39%、46.25%、45.71%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718005144941f7f85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240718005144941f7f85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139","IE0009354923.USD"],"gpt_icon":0},{"id":"2446564785","title":"Vaxcyte, Inc.盘中异动 下午盘急速拉升5.06%报78.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2446564785","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446564785?lang=zh_cn&edition=full","pubTime":"2024-06-28 02:52","pubTimestamp":1719514343,"startTime":"0","endTime":"0","summary":"北京时间2024年06月28日02时52分，Vaxcyte, Inc.股票出现波动，股价大幅拉升5.06%。截至发稿，该股报78.85美元/股，成交量126.485万股，换手率1.16%，振幅5.92%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628025223af8f8e0c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240628025223af8f8e0c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139"],"gpt_icon":0},{"id":"2440491965","title":"Vaxcyte, Inc.盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2440491965","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2440491965?lang=zh_cn&edition=full","pubTime":"2024-06-03 22:42","pubTimestamp":1717425745,"startTime":"0","endTime":"0","summary":"北京时间2024年06月03日22时42分，Vaxcyte, Inc.股票出现异动，股价快速拉升5.04%。截至发稿，该股报73.81美元/股，成交量11.0561万股，换手率0.10%，振幅4.78%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为1.44%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603224225941ebed7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240603224225941ebed7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PCVX"],"gpt_icon":0},{"id":"2438009671","title":"Vaxcyte Inc申请混合货架；规模未披露——美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2438009671","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438009671?lang=zh_cn&edition=full","pubTime":"2024-05-25 05:15","pubTimestamp":1716585303,"startTime":"0","endTime":"0","summary":"Vaxcyte Inc申请混合货架；规模未披露——美国证券交易委员会备案","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250515059ee4d049&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405250515059ee4d049&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PCVX"],"gpt_icon":0},{"id":"2438096383","title":"Vaxcyte Inc申请混合货架；规模未披露——美国证券交易委员会备案","url":"https://stock-news.laohu8.com/highlight/detail?id=2438096383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438096383?lang=zh_cn&edition=full","pubTime":"2024-05-25 05:06","pubTimestamp":1716584800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["PCVX","BK4139"],"gpt_icon":0},{"id":"2434045252","title":"Vaxcyte 公司报告截至 3 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2434045252","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2434045252?lang=zh_cn&edition=full","pubTime":"2024-05-10 01:59","pubTimestamp":1715277572,"startTime":"0","endTime":"0","summary":"   * Vaxcyte Inc   报告，截至3月底的季度调整后每股亏损85美分，低于去年同期的每股-70美分。九位分析师对该季度的平均预期是每股亏损 1.17 美元。华尔街预期为每股亏损 1.72 美元至-84 美分。* Vaxcyte Inc公布的季度每股收益为亏损85美分。* 该公司当季亏损 9502 万美元。* Vaxcyte Inc 本季度股价下跌了 2.2%，今年迄今为止上涨了 6.4%。5月9日 - 预测变化   * 过去三个月，分析师的平均盈利预期下降了约 12.4%。华尔街对 Vaxcyte Inc 的 12 个月目标价中位数为 102.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX","BK4139"],"gpt_icon":0},{"id":"2432359096","title":"Vaxcyte, Inc.盘中异动 大幅拉升5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432359096","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2432359096?lang=zh_cn&edition=full","pubTime":"2024-05-02 02:48","pubTimestamp":1714589289,"startTime":"0","endTime":"0","summary":"北京时间2024年05月02日02时48分，Vaxcyte, Inc.股票出现异动，股价大幅拉升5.20%。Vaxcyte, Inc.股票所在的生物技术行业中，整体涨幅为1.87%。其相关个股中，Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、Bioatla, Inc.涨幅较大，Palisade Bio, Inc.、Cyclacel Pharmaceuticals, Inc.、Cytomx Therapeutics, Inc.较为活跃，换手率分别为1408.06%、1168.68%、262.41%，振幅较大的相关个股有Cytomx Therapeutics, Inc.、Cyclacel Pharmaceuticals, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为188.34%、99.53%、77.43%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020248107925a4cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405020248107925a4cb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PCVX"],"gpt_icon":0},{"id":"2427756684","title":"Vaxcyte, Inc.盘中异动 大幅下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427756684","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2427756684?lang=zh_cn&edition=full","pubTime":"2024-04-13 02:02","pubTimestamp":1712944963,"startTime":"0","endTime":"0","summary":"北京时间2024年04月13日02时02分，Vaxcyte, Inc.股票出现波动，股价快速下挫5.07%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为1.36%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。该信息摘要如下：Needham：重申Vaxcyte评级，由买入调整至买入评级, 目标价95.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130202437a527b5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404130202437a527b5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139"],"gpt_icon":0},{"id":"2425895396","title":"【值得买入！Needham：制药行业并购潮中，这三只美股最可能被收购】智通财经获悉，据投行Needham分析师称，Phathom Pharmaceuticals(PHAT.","url":"https://stock-news.laohu8.com/highlight/detail?id=2425895396","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2425895396?lang=zh_cn&edition=full","pubTime":"2024-04-08 14:23","pubTimestamp":1712557405,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","BK4007","PCVX","BK1574","BK0217","BK4139","BK4585","300785","RYTM","BK4588","PHAT","01477"],"gpt_icon":0},{"id":"2419698529","title":"Vaxcyte, Inc.盘中异动 早盘股价大跌5.09%报69.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419698529","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2419698529?lang=zh_cn&edition=full","pubTime":"2024-03-14 23:08","pubTimestamp":1710428884,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日23时08分，Vaxcyte, Inc.股票出现异动，股价急速跳水5.09%。截至发稿，该股报69.52美元/股，成交量8.7059万股，换手率0.08%，振幅4.25%。Vaxcyte, Inc.股票所在的生物技术行业中，整体跌幅为0.62%。Vaxcyte, Inc.公司简介：Vaxcyte Inc 是一家疫苗公司，致力于通过开发新型疫苗来治疗患有最常见和致命疾病的患者，从而改善全球健康状况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230805861de460&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240314230805861de460&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139"],"gpt_icon":0},{"id":"2416964119","title":"Vaxcyte, Inc.2023财年实现净利润-4.02亿美元，同比减少80.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416964119","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2416964119?lang=zh_cn&edition=full","pubTime":"2024-03-03 00:24","pubTimestamp":1709396647,"startTime":"0","endTime":"0","summary":"12月31日，Vaxcyte, Inc.公布财报，公告显示公司2023财年净利润为-4.02亿美元，同比减少80.27%；其中营业收入为0.00美元，每股基本收益为-4.14美元。从资产负债表来看，Vaxcyte, Inc.总负债1.67亿美元，其中短期债务7.11百万美元，资产负债比为8.44，流动比率为7.56。机构评级：截至2023年12月31日，当前有7家机构对Vaxcyte, Inc.目标价做出预测，其中目标均价为97.00美元，其中最低目标价为69.00美元，最高目标价为108.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030024108afa651c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403030024108afa651c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX"],"gpt_icon":0},{"id":"2415737274","title":"Vaxcyte Inc盘中异动 大幅下挫5.03%报76.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2415737274","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2415737274?lang=zh_cn&edition=full","pubTime":"2024-02-29 00:47","pubTimestamp":1709138828,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日00时47分，Vaxcyte Inc股票出现异动，股价快速下跌5.03%。截至发稿，该股报76.97美元/股，成交量26.909万股，换手率0.25%，振幅6.14%。Vaxcyte Inc股票所在的生物技术行业中，整体跌幅为0.52%。其相关个股中，Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc涨幅较大，Adial Pharmaceuticals Inc、Vivani Medical Inc、Revelation Biosciences Inc较为活跃，换手率分别为4995.47%、205.15%、83.68%，振幅较大的相关个股有Vivani Medical Inc、Adial Pharmaceuticals Inc、Vtv Therapeutics Inc，振幅分别为424.75%、219.84%、121.41%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290047087a47c9ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402290047087a47c9ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PCVX"],"gpt_icon":0},{"id":"2413474563","title":"Vaxcyte Inc   预计每股亏损1.07美元 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2413474563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2413474563?lang=zh_cn&edition=full","pubTime":"2024-02-24 08:01","pubTimestamp":1708732890,"startTime":"0","endTime":"0","summary":"   * Vaxcyte Inc    将于2月27日公布截至2023年12月31日的财报，预计该公司的季度收入将保持不变。*    * LSEG的分析师平均预计Vaxcyte Inc每股亏损1.07美元。* 华尔街对 Vaxcyte Inc 的 12 个月目标价中位数为 76.00 美元，低于其最新收盘价 76.87 美元。2月24日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PCVX"],"gpt_icon":0},{"id":"2413790812","title":"Vaxcyte Inc盘中异动 下午盘快速拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2413790812","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2413790812?lang=zh_cn&edition=full","pubTime":"2024-02-24 02:50","pubTimestamp":1708714240,"startTime":"0","endTime":"0","summary":"北京时间2024年02月24日02时50分，Vaxcyte Inc股票出现波动，股价大幅拉升5.00%。截至发稿，该股报77.56美元/股，成交量46.5341万股，换手率0.43%，振幅4.43%。Vaxcyte Inc股票所在的生物技术行业中，整体涨幅为0.51%。Vaxcyte Inc公司简介：Vaxcyte Inc是一家疫苗公司，致力于通过开发新型疫苗来治疗最常见和致命疾病的患者来改善全球健康。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240250417a462e83&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202402240250417a462e83&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCVX","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vaxcyte.com","stockEarnings":[{"period":"1week","weight":0.0057},{"period":"1month","weight":-0.0682},{"period":"3month","weight":0.154},{"period":"6month","weight":0.0323},{"period":"1year","weight":0.6073},{"period":"ytd","weight":0.2635}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vaxcyte, Inc.于2013年11月27日在特拉华州注册成立。该公司是一家下一代疫苗公司，旨在通过开发预防或治疗全球某些最常见和致命的传染病的新型疫苗来改善全球健康状况。他们的无细胞蛋白质合成平台使他们能够设计和生产蛋白质载体和抗原，这是疫苗的关键组成部分。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.048351},{"month":2,"riseRate":0.5,"avgChangeRate":0.028598},{"month":3,"riseRate":0.25,"avgChangeRate":-0.069811},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00703},{"month":5,"riseRate":0.75,"avgChangeRate":0.110566},{"month":6,"riseRate":0.75,"avgChangeRate":0.01461},{"month":7,"riseRate":0.4,"avgChangeRate":0.004916},{"month":8,"riseRate":1,"avgChangeRate":0.174209},{"month":9,"riseRate":0.25,"avgChangeRate":-0.010728},{"month":10,"riseRate":0.25,"avgChangeRate":0.109931},{"month":11,"riseRate":0.5,"avgChangeRate":-0.034401},{"month":12,"riseRate":0.75,"avgChangeRate":0.062284}],"exchange":"NASDAQ","name":"Vaxcyte, Inc.","nameEN":"Vaxcyte, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Vaxcyte, Inc.,PCVX,Vaxcyte, Inc.股票,Vaxcyte, Inc.股票老虎,Vaxcyte, Inc.股票老虎国际,Vaxcyte, Inc.行情,Vaxcyte, Inc.股票行情,Vaxcyte, Inc.股价,Vaxcyte, Inc.股市,Vaxcyte, Inc.股票价格,Vaxcyte, Inc.股票交易,Vaxcyte, Inc.股票购买,Vaxcyte, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Vaxcyte, Inc.(PCVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Vaxcyte, Inc.(PCVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}